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Abstract: Abstract 
Perineural invasion is a clear route for cancer cell spread however; the 
role of nerves in cancer progression is relatively unknown. Recent 
work would suggest that nerves can actively infiltrate the tumour 
microenvironment and stimulate cancer cell growth.  Therefore, the aim 
of the present study was to systematically review the identification and 
associations of perineural invasion and survival in patients with primary 
operable colorectal cancer. 
From initial search results of 912 articles, 38 studies were selected. 
Using H&E stains; five studies including 1835 patients reported on 
survival stratified by perineural invasion in colon cancer with weighted 
average detection rates of 26%; eleven studies including 3837 patients 
reported on rectal cancer with weighted average detection rates of 25% 
and; sixteen studies including 9145 patients reported on survival 
stratified by perineural invasion in colorectal cancer with weighted 
average detection rates of 17%. Using special techniques (S100), six 
studies including 1458 patients reported on the identification of 
perineural invasion in colorectal cancer. In comparison to H&E staining 
alone, the use of immunohistochemistry with S100 increased the 
detection of perineural invasion to approximately 70%. However, those 
studies did not examine the relationship with outcomes, so further 
research is required to establish the clinical significance of perineural 
invasion detected by immunohistochemistry. 
In conclusion, perineural invasion deserves special attention for 
improved prognostic stratification in patients with colorectal cancer. 
Further work is required to standardise pathology assessment and 
reporting of perineural invasion, in particular its definition, use of 
special stains and routine inclusion in pathology practice. Reliable 
assessment is required for investigations into mechanisms of perineural 
invasion, its role tumour spread and prognostic value. 
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Abstract 
Perineural invasion is a clear route for cancer cell spread however, the role of nerves in 
cancer progression is relatively unknown. Recent work would suggest that nerves can 
actively infiltrate the tumour microenvironment and stimulate cancer cell growth. Therefore, 
the aim of the present study was to systematically review  the identification and associations 
of perineural invasion and survival in patients with primary operable colorectal cancer. 
 
From initial search results of 912 articles, 38 studies were selected.  Using H&E stains; five 
studies including 1835 patients reported on survival stratified by perineural invasion in colon 
cancer with weighted average detection rates of 26%; eleven studies including 3837 patients 
reported on rectal cancer with weighted average detection rates of 25% and; sixteen studies 
including 9145 patients reported on survival stratified by perineural invasion in colorectal 
cancer with weighted average detection rates of 17%.  Using special techniques (S100), six 
studies including 1458 patients reported on the identification of perineural invasion in 
colorectal cancer.  In comparison to H&E staining alone, the use of immunohistochemistry 
with S100  increased the detection of perineural invasion to approximately 70%.  However, 
those studies did not examine the relationship with outcomes, so further research is required 
to establish the clinical significance of perineural invasion detected by  
immunohistochemistry. 
 
In conclusion, perineural invasion deserves special attention for improved prognostic 
stratification in patients with colorectal cancer.  Further work is required to standardise 
pathology assessment and reporting of perineural invasion, in particular its definition, use of 
special stains and routine inclusion in pathology practice.  Reliable assessment is required 
for investigations into mechanisms of perineural invasion, its role tumour spread and 
prognostic value. 
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1: INTRODUCTION 
Colorectal cancer is a major cause of both cancer incidence and mortality [1].  Currently, 
Tumour-Node-Metastasis (TNM) staging is considered the most robust predictor of outcome 
of patients with colorectal carcinoma but is less accurate in early stage disease. Thus 
supplemental risk factors are required to allow selection of patients who may benefit from 
adjuvant treatment [2]. 
 
Currently the indication for  adjuvant therapy for patients with stage II disease is  based on 
the presence of at least one of six clinical and pathological high risk factors ;poor 
differentiation, emergency surgery, fewer than 12 examined lymph nodes, the presence of 
extramural vascular invasion, perforation or a pT4 tumour [3].  However, additional features, 
such as perineural invasion and the presence of tumour budding are recognised risk factors 
that do not yet influence treatment decisions. As such, perineural invasion has been 
included in the TNM Supplement for colorectal cancer since 2001[4].   Perineural invasion is 
also identified as a site- specific prognostic factor by the American Joint Committee on 
Cancer (AJCC)  Staging Manual (7th edition) and a high risk factor for recurrence under the 
National Comprehensive Cancer Network (NCCN) guidelines.  Perineural invasion is 
included in the Royal College of Pathologists dataset (UK) to be reported as microscopic 
non-core data for colorectal cancer [5]. 
 
Metastatic disease is the principle cause of death in colorectal cancer, tumour dissemination 
via blood and lymphatic vessels are accepted as the dominant routes of malignant spread 
[6].  However, tumour spread via nerves is plausible as an alternative route of spread and 
can therefore influence possible treatment prevention. 
 
Perineural invasion has recently emerged as a key pathologic feature of several common 
solid cancers, including pancreas, prostate, biliary tract, and stomach.  Neoplastic cells in 
perineural spaces may not be removed during tumour resection, and thus may result in local 
recurrence [7].  Perineural invasion in colorectal cancer has been reported as an 
independent prognostic factor [8, 9, 10] however, is not always assessed and reported. 
Problems with the detection of perineural invasion such as the presence of inflammatory 
cells, mucinous carcinoma and microscopic foci of perineural invasion can hinder consistent 
reporting. Presently, the clinical significance of perineural invasion remains unclear. 
 
The aim of the present study was therefore to systematically review the identification of 
perineural invasion and associations with clinopathological features and survival in patients 
with primary operable colorectal cancer. 
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2: METHODS 
A systematic review of the published literature on perineural invasion in colorectal cancer 
was undertaken. In addition to methods of assessment, outcomes of interest were 
relationships with other clinical and pathological factors and cancer outcomes (cancer- 
specific survival / overall survival). 
 
Studies were identified via a literature search of the electronic databases the US National 
Library of Medicine (MEDLINE), the Excerpta Medical database (EMBASE), the Cochrane 
Database of Systematic Reviews (CDSR) and the Database of Abstracts and Reviews 
(DARE) between 1984 and 2015 using the key words: perineural invasion, nerve, 
colon/rectal cancer and prognosis (last search was updated on December 3, 2015). 
 
For inclusion, studies had to meet the following criteria: (a) perineural invasion was   
assessed in surgically resected primary colon and /or rectal tumours, and (b) the relationship 
between perineural invasion and survival was investigated in primary operable disease, and 
the results were published as a full paper.  Studies that only reported perineural invasion as 
an incidental finding were excluded. 
 
The title and abstract of each identified study was examined for relevance.  Full text was 
obtained for all potentially relevant studies. Studies that examined the prognostic value of 
perineural invasion in colon and /or rectal cancer were included while studies relating to 
duplicate datasets, studies not available in English language and those published only in 
abstract form were excluded.  Studies in which sample size was less than 75 patients and 
the median/mean follow-up was less than 3 years were also excluded.  The bibliographies of 
all included articles were subsequently hand searched to identify any additional studies. 
Studies were selected after review by the author (HvW) or if there was doubt with another 
co-author (DCM). 
 
Study heterogeneity precluded a meaningful meta-analysis and the results of the review are 
presented in descriptive form with specific reference to definitions, localisation and 
assessment of perineural invasion and the effects of these on incidence, outcomes, 
including survival and characteristics of the tumour microenvironment in primary operable 
colon and /or rectal cancer. 
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3: RESULTS 
 
SEARCH RESULTS 
A total of 912 potentially relevant articles were retrieved by the database search. 853 
articles were excluded as they did not meet inclusion criteria (Fig. 1). Cross-referencing 
resulted in 4 additional articles that fulfilled the eligibility criteria.  After exclusion of 25 
studies as a result of incidental reporting of perineural invasion, 38 studies were reviewed. 
 
INTERPRETATION OF RESULTS 
Several factors influence recognition and interpretation of perineural invasion in colorectal 
cancer. 
 
I) Currently, there is no concise, accepted definition of perineural invasion in cancer and this 
prevents consistent prospective reporting of perineural invasion by pathologists.  According 
to Batsakis (1984) [11], perineural invasion is tumour cell invasion in, around, and through 
nerves.   Liebig et al. (2009)[12] has advocated a definition of perineural invasion; that 
include tumour cells in close proximity to neural structures (involving at least 33% of the 
neural circumference) or tumour cells within any of the 3 layers of the nerve sheath.   In the 
large bowel, there are no site-specific rules for the identification of perineural invasion as two 
neural plexuses are located in the submucosa.   One plexus lies immediately beneath the 
muscularis mucosa (Meissner plexus) and the deeper (Auerbach’s myenteric plexus). 
Invasion of Auerbach’s plexus is seldom recorded but may be important in terms of  
research.   Fujita (2007), [13] defined perineural invasion as cancer cells inside the 
perineurium in the Auerbach plexus adjacent to the tumour front.   Ueno et al.2013 [14] 
defined cancer spread along nerves of Auerbach’s plexus as intramural perineural invasion 
and extramural perineural invasion as tumour cells invading or spreading along nerve 
fascicles external to the muscularis propria.   Although perineural invasion has been 
observed intramurally and extramurally, the incidence and prognostic value based on  
location relative to the bowel wall have not been clarified.   Perineural invasion is mostly 
reported as extramural (external to the muscularis propria) in the absence of more specific 
guidance. The AJCC Cancer Staging Manual also does not specify the bowel layer where 
perineural invasion should be recorded as a site-specific prognostic marker. These 
definitions and sites have been included in the present review. 
 
II) Since reporting of perineural invasion is not part of standard pathology practice, many 
studies report perineural invasion as recorded incidentally without systematic prospective 
reporting or a retrospective review of pathology sections. Only studies were included in 
which perineural invasion was recorded as part of pathology review or prospectively when 
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systematically reported as a prospective part of standard pathology practice.  Twenty five 
studies were excluded on this basis. 
 
III) Most studies combine the results of perineural invasion in colonic and rectal cancer, but 
the colon and the rectum have anatomically different patterns of innervations.  Most of the 
colon is intraperitoneal with no external plexus, while the rectum is largely extraperitoneal 
and has its own rectal plexus.  Therefore, the colon and rectum have different innervation 
densities and rectal cancer is potentially more able to induce neuroplasticity as a 
consequence of higher innervation density due to proximity of large-calibre nerve trunks in 
the mesorectum compared to the mesocolon [15].   As a result perineural invasion was 
considered in terms of colon cancer, rectal cancer, and both. 
 
IV) Routine practice is to use H&E sections for identification of perineural invasion but some 
studies utilised immunohistochemistry to improve identification of perineural invasion in 
colorectal cancer [16].  S100 is a specific marker of neural fibres of the peripheral nervous 
system and has been considered  useful in the identification of perineural invasion by 
immunohistochemistry. Both H&E and immunohistochemical studies have been included in 
the present review. 
 
3.1 PROSPECTIVE STUDIES USING H&E TO IDENTIFY PERINEURAL INVASION IN 
PATIENTS WITH COLON, RECTAL AND COLORECTAL CANCER 
 
3.1.1 COLON CANCER 
Five studies including 1835 patients reported on survival stratified by perineural invasion in 
colon cancer using H&E sections (Table 1). In these studies the weighted average detection 
rate for perineural invasion was 26%, range 13 - 39%. 
 
Perineural invasion was associated with high tumour stage, poor tumour differentiation and 
the incidence of metastasis at diagnosis.   Perineural invasion was independently associated 
with poor survival in 3 of 5 studies, 1 of 5 studies confirmed a positive association on 
univariate analyses only and 1 of 5 studies reported no association with survival (both 
overall and cancer specific survival).   Age, T4 stage, venous invasion and pre-operative 
CEA levels were also independently associated with poor survival. 
 
Two studies supplied a definition for perineural invasion. All studies reported on extramural 
perineural invasion. 
 
In summary, with H&E stains, perineural invasion was identified in approximately 26% of 
patients with primary operable colon cancer. Only extramural perineural invasion was 
reported and was independently associated with survival. 
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3.1.2 RECTAL CANCER 
Eleven studies including 3837 patients reported on survival stratified by perineural invasion 
in rectal cancer using H&E sections (Table 2). In these studies the weighted average 
detection rate for perineural invasion was 25%, range 10 - 38%. 
 
Perineural invasion was significantly associated with high tumour stage, poor tumour 
differentiation, incidence of metastasis at time of diagnosis, lymphatic and venous invasion. 
 
Perineural invasion was independently associated with poor survival in 7 of 11 studies, 3 of 
11 studies confirmed a positive association on univariate analyses only and 1 of 11 studies 
reported no association with survival (mostly overall survival).   Age, tumour stage, nodal 
status, venous invasion and CEA levels were also independently associated with poor 
survival. 
 
In summary, with H&E stains, perineural invasion was identified in approximately 25% of 
patients with primary operable rectal cancer.  Six studies supplied a definition of perineural 
invasion and only extramural perineural invasion was reported and was independently 
associated with survival. 
 
3.1.3 COLORECTAL CANCER 
Sixteen studies including 9145 patients reported on survival stratified by perineural invasion 
in colorectal cancer using H&E sections (Table 3).  In these studies the weighted average 
detection rate for perineural invasion was 17%, range 8- 42 %. 
 
Perineural invasion was significantly associated TNM stage, poor tumour differentiation, 
lymphatic and venous invasion.  Perineural invasion was independently associated with poor 
survival in 13 of 16 studies and 3 of 16 studies confirmed a significant association on 
univariate analyses only.  In 1 of 16 studies no association between perineural invasion and 
poor survival was found [32]. Gender, grade, T stage, N stage, lymphovascular invasion, 
tumour budding, tumour necrosis, peritumoral lymphocytic infiltration and CEA levels were 
also independently associated with poor survival. 
 
Three studies reported on both intra and extramural perineural invasion [13, 14, 42]. Fujita 
[13] defined perineural invasion as cancer invasion to the Auerbach plexus and reported 
perineural invasion to be a more important prognostic factor than venous and lymphatic 
invasion in patients with colorectal cancer.  Ueno et al, 2013 [14], defined intramural 
perineural invasion as cancer spread along the Auerbach plexus and extramural perineural 
invasion as the histological finding of tumour cells invading or spreading along nerve 
fascicles external to the muscularis propria.  In their study extramural perineural invasion 
was further examined, depth and incidence (number of foci) were also evaluated.  Ueno 
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further reported that staging could be enhanced by site-specific criteria as well as a grading 
system based on the location of perineural invasion within the bowel wall. The study by 
Suzuki (2015) [42] also reported both intra and extramural perineural invasion. 
 
An earlier study by Ueno (2001) [27] reported a three- tier grading system that included 
intensity and depth of perineural invasion, with an association with survival and local 
recurrence, independent of TNM stage. 
 
In summary, with H&E stains, perineural invasion was identified in approximately 17% of 
patients with primary operable colorectal cancer.   Six studies supplied a definition for 
perineural invasion while 3 studies reported on both intramural and extramural invasion 
however most studies reported only extramural perineural invasion and was independently 
associated with survival. 
 
3.2 STUDIES USING SPECIAL STAINS/ TECHNIQUES TO IDENTIFY PERINEURAL 
INVASION IN COLORECTAL CANCER 
The identification of perineural invasion using H&E staining varied between 8 % and 42 %. 
Review of slides reported an improvement of detection of perineural invasion however 
special stains using immunohistochemistry with anti-S 100 protein has been proposed to 
improve the identification of perineural invasion [16].  However, S100 is not the only 
neuronal biomarker used to detect nerves and individual axons in cancer. PGP9.5 has also 
been used to detect nerves in the cancer microenvironment.  PGP9.5, an ubiquitin 
hydrolase, is widely expressed in neuronal tissues and has been suggested as a neuro 
endocrine marker [47,48]. However, the prognostic value of this staining has yet to be 
determined. 
 
Six studies including 1458 patients reported on the identification of perineural invasion in 
colorectal cancer using special techniques (Table 4).  Most were comparative studies that 
showed an increased in detection of perineural invasion with S100 protein. The detection 
rates were up to 70% with the use of S100 protein. 
 
Perineural invasion (S100) was significantly associated with the TNM stage, poor tumour 
differentiation and lymphatic invasion.  Only the study by Shimada et al, 2014 (n=184) [46] 
showed that perineural invasion detected by immunohistochemistry with S100 protein was 
independently associated with poor survival.  The inter-observer assessment showed 
superior reproducibility in comparison to H&E staining. 
 
In summary, the use of S100 protein increased detection of perineural invasion in patients 
with primary operable colorectal cancer.  Furthermore, results suggested that the use of 
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immunohistochemistry with S100 protein could be of value in the identification of perineural 
invasion.  Further studies are warranted to assess the effect on outcome. 
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4. DISCUSSION 
In this systematic review of more than thirty studies, perineural invasion was independently 
prognostic in primary operable colon and rectal cancer.  Age, gender, TNM stage, venous 
invasion, tumour necrosis, peri- tumoural lymphocytic infiltration, tumour budding and CEA 
levels were also independently associated with poor survival in at least some studies [17, 18, 
21, 22, 26, 30, 32, 33, 39]. 
 
Perineural invasion was consistently associated with poor differentiation, T stage, incidence 
of metastasis at time of diagnosis, lymphatic and venous invasion. All of these are 
established histopathologic factors, indicative of aggressive behavior in colorectal cancer, 
and therefore suggest that perineural invasion can  also be used as surrogate marker for an 
aggressive phenotype of colorectal cancer. 
 
Thus, even though perineural invasion is not routinely reported, it can play an important role 
in the stratification of colorectal cancer and consideration should therefore be given to 
routine assessment of “perineural invasion status” in primary colorectal cancer specimens. 
 
Furthermore, results of the present review suggested that  in studies where perineural 
invasion was well defined, detection rates were higher.  However it is not clear whether this 
increased detection rate was associated with better prediction of outcome.  Further studies 
are warranted to examine the relationship between the assessment of perineural invasion 
and the prediction of outcome. Interobserver variability in the assessment of perineural 
invasion still needs to be further evaluated, as little information concerning the reproducibility 
of perineural invasion exists in the literature [14]. 
 
In the present review no difference could be demonstrated between the incidence, 
association and outcome of perineural invasion in colon and /or rectal cancer despite the 
anatomic differences in nerve supply.  However, a small number of studies reported on colon 
cancer only and therefore no conclusion could be made.. 
 
It was clear that immunohistochemistry can be used to improve detection of perineural 
invasion with an antibody against S-100 protein with reported incidence of 70 percent, 
approximately more than 3 times the incidence utilising routine H&E staining [16].  Results 
from the present review suggested the use of immunohistochemistry in identification of 
perineural invasion could be useful despite the labour, time, and cost involved.  However, 
further research is required to directly compare the H&E and special stain approaches and 
the prediction of outcomes in patients with colorectal cancer and the clinical relevance. 
 
The association of perineural invasion with  histopathologic factors, indicative of  tumour 
spread (lymphatic invasion and venous invasion) suggest these factors can all be part of 
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steps in the metastatic processes that include vascular emboli, lymphatic invasion, and 
perineural invasion (collectively referred to as VELIPI (Pages et al.2008) [10]. Tumour 
progression still remains the main cause of death for patients with colorectal cancer 
however; the mechanisms that produce metastases  remain poorly understood and further 
studies are required to clarify the association between VELIPI (collective) and cancer 
progression.. 
 
Nerves involved in perineural invasion may be considered passive as they provide a channel 
for cancer cell dissemination. However, recently the infiltration of the tumour 
microenvironment by nerves has provided evidence that there is an active process involved 
termed, tumour neoneurogenesis and has been associated with cancer progression [7]. 
Infiltrating nerve fibres can stimulate tumour growth and dissemination, while tumour cells 
can drive nerve outgrowth in a cross-talk that contributes to tumour progression [49]. 
 
Cancer cell growth can be stimulated by receptors for autonomic neurotransmitters through 
activation of the corresponding signalling pathways [50]. Autonomic neurotransmitters can 
also stimulate endothelial cells, immune cells, and fibroblasts thus having an impact on the 
tumour microenvironment [51]. Moreover, it has recently been reported that nerves in 
prostate and gastric tumours, release neurotransmitters directly into the vicinity of cancer 
cells to stimulate survival, proliferation, and the ability to spread [52,53]. 
 
The effect of receptors for autonomic neurotransmitters is not yet known in colorectal cancer 
although the microenvironment of colorectal cancer is rich in autonomic nerve fibres. 
Furthermore, the potential impact of nerves on colorectal cancer progression has not been 
reported and therefore it is still to be determined whether a similar nerve dependent tumour 
growth takes place [49]. 
 
Previously, a potential explanation for the strong association between colorectal cancer liver 
metastases and perineural invasion was that the liver is richly innervated by autonomic 
nerve fibres and those sympathetic fibre innervations in the liver may share a preganglionic 
origin with the sympathetic nerves that innervate the colon and rectum [54]. However, 
despite the findings of perineural invasion as a strong independent prognostic factor in 
colorectal cancer; the role of neurogenesis in colorectal cancer still remains unclear [55]. 
 
Recently Knijn et al. 2016, carried out a systematic review and meta-analysis of the 
prognostic value of perineural invasion in patients with colorectal cancer and they concluded 
that ”perineural invasion should be one of the features in the standardised reporting of CRC 
and might be considered a high-risk feature” [56]. 
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However, unlike the present review they did not consider the importance of (I) the variable 
definition of perineural invasion in colorectal cancer (II) retrospective nature of most studies 
in the literature (III) the importance of site in colon and rectum (IV) the different staining 
approaches to the detection of perineural invasion and their impact on the relationship with 
survival. 
 
Consideration of these, results in a more limited conclusion that results of the present review 
suggest that perineural invasion has promise as an independent prognostic factor in patients 
with colorectal cancer. However, further research is required to (a) devise an optimal method 
for detection of perineural invasion, (b) to establish prognostic value of the optimal method 
and (c) for this methodology to be externally validated. 
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Table 1: Relationship between perineural invasion and survival in colon cancer. 
 
Study Year Number 
(N) 
Site Follow 
up 
Stage Invasion 
(%) 
Method Definition Outcome 
measure 
Results 
Weid [17] 1984 442 Colon 5 year I-III 39 Routine 
H&E 
Not 
mentioned 
Overall survival 
(OS) 
Significantly 
associated with OS 
P=0.05 ( age & venous 
invasion independent 
factors) 
Quah [18] 2007 448 Colon 5 year II 14 Standard 
routine 
reporting 
None Disease specific survival 
(DSS) 
Independent 
prognostic factor DSS 
P=0.04,HR also Stage 
T4 & pre-op CEA 
levels 
Poeschl [19] 2010 195 Colon 45 months I-IV 13 Review None Cancer specific survival 
(CSS), Progression free 
survival (PFS) 
Independent 
prognostic factor for 
both CSS p=0.002, 
PFS p<0.001 
Canney [20] 2012 77 Colon 5 year II 22 Review Perineural, 
epineural, 
myenteric 
plexus 
Overall survival Independent 
prognostic factor OS 
p=0.02 
Liebl [15] 2013 673 Colon 64 months All 31 Routine 
8 slides 
4 categories Overall survival Not independent 
prognostic factor 
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Table 2: Relationship between perineural invasion and survival in rectal cancer. 
 
Study Year N Site Follow 
up 
Stage Neo 
adjuvant 
Invasion 
(%) 
Method Definition Outcome 
measure 
Result 
Knudsen 
[21] 
1983 682 Rectal 5 year I-III No 35 Routine 
H&E 
Tumour cells outside 
muscle wall 
5 year survival Independent prognostic factor 
also venous invasion 
Bentzen [22] 1988 468 Rectal 5 year II-III No Stage II 17 Not mentioned None Overall survival Independent prognostic factor 
OS p=0.004 
Stage III 
38 
Not mentioned None Overall survival Independent prognostic factor 
OS  p=0.003 also venous 
invasion, CEA (elevated) and 
tumour diameter 
Horn [23] 1990 254 Rectal 5 year I-III Yes  Routine In and outside of bowel 
wall 
5 year survival Worse 5 yr survival rates also 
venous invasion 
Shirozou 
[24] 
1992 501 Rectal 8 year I-III Unknown 20 Routine Cancer cells inside 
perineum   extramural 
(Auerbach rare) 
5 year, 8 year 
survival 
Independent prognostic factor 
p<0.005 
Shirozou 
[25] 
1993 373 Rectal 8 year I-III Unknown 10 Routine Extramural 8 year survival Worse 8yr survival rates 
p<0.001 
Bognel [26] 1995 339 Rectal 5 year I-III  34 H&E and 
saffron 
Endoneural or perineural 
invasion 
Overall survival Independent prognostic factor 
OS p<0.001 also age, distance 
from anal verge, number of N+ 
nodes & tumour penetration 
Ueno [27] 2001 364 Rectal 5 year II-III No 14 H&E Extramural 
3 Grade system based on 
intensity and depth of 
invasion 
5 year survival Independent prognostic factor 
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Rullier [28] 2005 200 Rectal 48 months II-III Yes 15.5 Routine None Overall survival , 
Disease free 
survival 
Significantly associated with OS 
p=0.04,DFS  p=0.001 (univariate 
analysis) 
Poeschl [19] 2010 155 Rectum 45 months I-IV No 18 Not mentioned None Cancer specific 
survival, 
Progression free 
survival 
Independent prognostic factor 
for both CSS p=0.04, 
PFS p=0.05 
Peng [29] 2011 173 Rectal 49 months II No Review 24 
Original 
8 
Review 2 groups: 
SS-PNI :surround sheath 
TS-PNI : through sheath 
Overall survival, 
Disease free 
survival 
No significant association with 
survival only with local 
recurrence 
Lee [30] 2012 328 Rectal 5 year I-III Yes 20 Routine slides None Overall survival, 
Disease free 
survival 
Independent prognostic factor 
for DFS p=0.046 also 
lymphovascular invasion ( both 
DFS,OS) 
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Table 3: Relationship between perineural invasion and survival in colorectal cancer. 
 
Study Year Number Site Follow 
up 
Stage Invasion 
(%) 
Method Definition Outcome 
measure 
Results 
Krasna [31] 1988 77 Colorectal 6 year I-III 14 Routine 
H&E reviewed 
Endoneural or perineural 
invasion 
Overall survival Worse 3 yr survival rates 
Mulcachy 
[32] 
1997 117 Colorectal 8.2 year II 8 Routine reviewed 
8 variables 
None 5 year survival Independent prognostic 
factor  p=0.03 also 
tumour necrosis 
Ocana [33] 2004 124 Colorectal 11.7 year I-II 42 Review 
Prospective review 
None Cancer specific 
survival 
Independent prognostic 
factor,CSS p=0.027 also 
gender, Tstage, grade and 
CEA levels 
Pages [10] 2005 959 Colorectal  I-IV 10 H&E 
Reassessed 
None Disease free 
survival , overall 
survival 
Significantly associated 
with OS,DFS, (univariate 
analysis) 
Fujita [13] 2007 509 Colorectal 5 year II-III 26 Review Extramural intramural - 
Auerbach plexus 
Disease free 
survival 
Independent prognostic 
factor  DFS p<0.0001 also 
T3-4 stage, N stage and 
cancer site) 
Tsai [34] 2008 259 Colorectal 32 months II 31 Routine reporting Cancer cells  observed 
extraneurally 
Overall survival No  association with OS 
Liebig [9] 2009 249 Colorectal 5 year I-IV 22 Review Tumour cells close to 
neural structures 33% 
of nerve circumference 
Overall survival, 
Disease free 
survival 
Independent prognostic 
factor OS p=0.03; 
DFS p=0.02 
Huh [35] 2010 341 Colorectal  II 17 Routine review None Overall survival, 
Disease free 
survival 
Significantly associated 
with DFS  p= 0.036 
(univariate analysis) 
Kang [36] 2011 229 Colorectal  II-III 21 Review of 
pathology 
None Overall survival Independent prognostic 
factor  OS  Stage II&III 
combined, P=0.013 and 
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          Stage III, p<0.001 
Allard [37] 2012 117 Colorectal 61 months II-III 21 Routine 
Reviewed slides 
None Disease free 
survival 
Significantly associated 
with DFS  p<0.01 
(univariate analysis) 
Huh [38] 2013 1437 Colorectal 56 months II-III 19 Routine None Overall survival, 
Disease free 
survival 
Independent prognostic 
factor for OS and DFS 
p<0.001 (both) also LVI 
Lee [39] 2013 333 Colorectal 5 year I-IV 8 H&E 
S100A4 
None Overall survival, 
Disease free 
survival 
Independent prognostic 
factor for OS p=0.010 
also stage, tumour 
budding and  peritumoral 
lymphocytic infiltration 
Ueno [14] 2013 Cohort 
1:962 
Colorectal 5 year I-III 16 H&E Intramural 
Extramural 
PN Grading system 
Disease free 
survival 
Independent prognostic 
factor for DFS p<0.0001 
Ueno [40] 2014 2845 Colorectal 5 year  18 H&E 
Reviewed 
Myenteric spread Overall survival, 
Disease free 
survival 
Independent prognostic 
factor for DFS p=0.0016 
Yun [41] 2014 409 Colorectal 5 year III 16 Reviewed None Overall survival, 
Disease free 
survival 
Independent prognostic 
factor for DFS p=0.002 
Suzuki [42] 2015 178 Colorectal 5 year I-III Not 
mentioned 
Reviewed Cancer cells in 
perineurium (Auerbach, 
Meissner plexus), or in 
peripheral 
nerves (intramural or 
extramural). 
Overall survival, 
Disease free 
survival 
Independent prognostic 
factor for OS in Stage III 
p=0.023 
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Table 4: Studies using special stains for detection of perineural invasion in colorectal cancer. 
 
Study Year N Site Stage Method Invasion (%) Outcome Agreement 
(K) 
Results 
Bellis [16] 1993 160 Colorectal  Anti-S100 14%  H&E 
70% IHC 
Not mentioned - Recommended 
routine  use 
Matsushima [43] 1998 128 Rectal  S100 30% Not mentioned - Worst prognosis 
Ueno [44] 2009 994 Colorectal I-III Anti-S100 PNI more often mode 
of  H spread 
(horizontal) 
Not mentioned - PNI in myenteric 
plexus 
predominant 
Ueno [14] 2013 50 Colorectal  Glut 1 40% Not mentioned - - 
White [45] 2013 44 Rectal I-IV S100 17%  H&E 
31%  REVIEW 
60%  IHC 
Not mentioned e ICC H&E (0.94) 
ICC S100 (0.72) 
- 
Shimada [46] 2014 184 Colorectal I-III S100 33% (H&E) 
61% (IHC) 
Overall survival, 
Recurrence free 
survival 
ICC H&E (0.47) 
ICC S100 (0.77) 
Independent 
prognostic factor 
for OS and RFS 
 Excluded  
Relevance title and 
abstract (n= 826) 
Language (n=6) 
Only abstract (n=8) 
Reviews (n=4) 
Duplicate data (n=4) 
Sample size < 75 (n=5) 
59 full text 
studies 
evaluated 
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Figure 1 Flow chart of study selection process 
912 Studies in 
database 
search 
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hand search 
reference lists 
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Incidental 
detection of 
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Studies (n=38) 
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perineural invasion and 
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